This is a preview of subscription content, log in via an institution to check access.
Reference
NICE. NICE recommends cabazitaxel for prostate cancer. Media Release : 22 Apr 2016. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
UK NICE recommends cabazitaxel for metastatic HRPC. PharmacoEcon Outcomes News 752, 39 (2016). https://doi.org/10.1007/s40274-016-3033-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3033-1